EUVIMEDEUVIMED entdecken
Vergleichsstudie

Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo

Wei Zhang, Shengrui Zhai, Jinfa Dou, Shoumin Zhang, Hongwei Liu

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-024-03717-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Wei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou,…. Hauptthemen laut MEDLINE: Vitiligo, Lasers, Excimer, Heterocyclic Compounds, 3-Ring, Anthracenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoLasers, ExcimerHeterocyclic Compounds, 3-RingAnthracenesLow-Level Light TherapyHumansFemaleMaleAdultTreatment OutcomeRetrospective StudiesMiddle AgedYoung AdultSeverity of Illness IndexQuality of LifeDisease ProgressionCombined Modality TherapyFace

Stichwörter der Autor:innen

308 nm excimer lightAdverse reactionsJAK inhibitorProgressing facial vitiligoTreatment outcomeUpadacitinib

Substanzen

upadacitinibHeterocyclic Compounds, 3-RingAnthracenes

Autor:innen und Institutionen

  • Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, 450003, China.
  • Faculty of Biomedical Engineering, Tianjin Medical University, Tianjin, 300070, China.
  • Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, 450003, China. 1831824589@qq.com.

Zitieren

APA

Zhang, W., Zhai, S., Dou, J., Zhang, S., & Liu, H. (2025). Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03717-3

Vancouver

Zhang W, Zhai S, Dou J, Zhang S, Liu H. Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo. Archives of Dermatological Research. 2025. doi:10.1007/s00403-024-03717-3

BibTeX
@article{Zhang2025,
  author = {Zhang, Wei and Zhai, Shengrui and Dou, Jinfa and Zhang, Shoumin and Liu, Hongwei},
  title = {Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-024-03717-3}
}
Kostenlos starten →